Translational Medicine

Medicine & Life Sciences

1. 4-1BB Ligand 12%
2. Anti-Idiotypic Antibodies 9%
3. Antibodies 18%
4. Antigens 8%
5. Antinuclear Antibodies 6%
6. Arthralgia 9%
7. Autoantibodies 46%
8. Autoimmune Diseases 100%
9. Autoimmune Hepatitis 9%
10. Autoimmunity 73%
11. B-Lymphocytes 7%
12. Biliary Liver Cirrhosis 12%
13. Biomarkers 10%
14. Blood Vessels 6%
15. Catalytic Domain 6%
16. Central Tolerance 6%
17. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 10%
18. Cigarette Smoking 14%
19. Cluster Analysis 11%
20. Coffee 20%
21. Colombia 25%
22. Coronavirus 59%
23. Cytokines 18%
24. Ebola Hemorrhagic Fever 10%
25. Ebolavirus 9%
26. Ecology 13%
27. Epidemics 6%
28. Epitopes 10%
29. ETP-46321 17%
30. Experimental Arthritis 8%
31. Extracellular Traps 11%
32. Fibrosis 7%
33. Focus Groups 6%
34. Genetic Background 7%
35. Genetic Predisposition to Disease 6%
36. glucose-regulated proteins 10%
37. HIV-1 6%
38. HLA Antigens 7%
39. Hyperprolactinemia 9%
40. IC 87114 7%
41. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome 13%
42. Immune System 12%
43. Immune Tolerance 8%
44. Immunoglobulin G 11%
45. Inbred NOD Mouse 6%
46. Infections 11%
47. Inflammation 6%
48. Interleukin-17 8%
49. Interleukin-6 11%
50. Latin America 25%
51. Liver Cirrhosis 6%
52. Lymphocyte Activation 7%
53. Meta-Analysis 32%
54. Metabolomics 11%
55. Microscopic Angioscopy 10%
56. Minor Salivary Glands 12%
57. Molecular Mimicry 16%
58. Mortality 8%
59. Neural Conduction 8%
60. Odds Ratio 6%
61. Oral Contraceptives 7%
62. Pandemics 20%
63. Papillomavirus Infections 8%
64. Patient Reported Outcome Measures 8%
65. Peripheral Tolerance 6%
66. Phosphatidylinositol 3-Kinases 14%
67. Phosphoinositide-3 Kinase Inhibitors 10%
68. Phospholipids 6%
69. Polymyalgia Rheumatica 10%
70. Population 9%
71. Precision Medicine 7%
72. Primary Immunodeficiency Diseases 9%
73. Prolactin 7%
74. Proteins 6%
75. Randomized Controlled Trials 9%
76. Raynaud Disease 9%
77. Regulatory T-Lymphocytes 6%
78. Rheumatic Diseases 9%
79. Rheumatoid Arthritis 27%
80. Rheumatoid Factor 7%
81. Safety 8%
82. SARS Virus 59%
83. Sjogren's Syndrome 8%
84. Smoking 7%
85. SS-A antibodies 12%
86. Systematic Reviews 40%
87. Systemic Lupus Erythematosus 28%
88. Systemic Scleroderma 20%
89. Systems Biology 8%
90. T-Lymphocytes 30%
91. Therapeutics 11%
92. Thermography 9%
93. Thyroid Diseases 25%
94. Thyroid Gland 8%
95. Type 1 Diabetes Mellitus 15%
96. Vaccination 14%
97. Vaccines 15%
98. Viral Envelope Proteins 10%
99. Zika Virus 10%
100. Zika Virus Infection 11%